The functional exercise capacity is correlated with global functioning in patients with schizophrenia

被引:63
作者
Vancampfort, D. [1 ,2 ]
Probst, M. [1 ,2 ]
Scheewe, T. [3 ]
Knapen, J. [1 ,2 ]
De Herdt, A. [2 ]
De Hert, M. [1 ]
机构
[1] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium
[2] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Heverlee, Belgium
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
关键词
6-minute walk test; global assessment of functioning; schizophrenia; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; CARDIOMETABOLIC RISK; CONCURRENT VALIDITY; ILLNESS; PEOPLE; HEALTH; LIFE; GUIDELINES; DISORDERS;
D O I
10.1111/j.1600-0447.2011.01825.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The 6-minute walk test (6MWT) is commonly used to measure the functional exercise capacity in chronic patients with cardiovascular diseases. The purpose of this study was to determine whether the 6MWT is associated with the global assessment of functioning (GAF) score in patients with schizophrenia. Methods: A total of 68 male and 25 female in-patients with schizophrenia (34.6 +/- 9.7 years; body mass index = 24.9 +/- 4.4) performed a 6MWT and were assessed with the GAF scale and the Psychosis Evaluation tool for Common use by Caregivers (PECC). Results: The mean distance walked on the 6MWT was 587.3 +/- 98.4 m, while the mean GAF score was 52.0 +/- 10.4. The Pearson's correlation coefficient between the 6MWT and the GAF score was 0.59 (P < 0.001), indicating a moderate association between both measures. The 6MWT was also significantly related to negative (r = -0.45, P < 0.001), depressive (r = -0.48, P < 0.001) and cognitive (r =, P) symptoms and with body mass index (r = -0.31, P < 0.005), smoking behaviour (r = -0.36, P < 0.001)) and dose of antipsychotic medication (r = -0.38, P < 0.001). Conclusion: Next to the GAF scale, clinicians in in-patient settings should consider incorporating the 6MWT into their test battery to measure the functional consequences of schizophrenia and its treatment.
引用
收藏
页码:382 / 387
页数:6
相关论文
共 38 条
[1]  
[Anonymous], 1998, PECC PSYCHOSIS EVALU
[2]  
ATS Statement, 2002, Am. J. Respir. Crit. Care Med., V166, P111, DOI [DOI 10.1164/RCCM.166/1/111, DOI 10.1164/AJRCCM.166.1.AT1102]
[3]  
Beebe Lora Humphrey, 2005, Issues Ment Health Nurs, V26, P661
[4]   Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort [J].
Bobes, Julio ;
Arango, Celso ;
Garcia-Garcia, Margarida ;
Rejas, Javier .
SCHIZOPHRENIA RESEARCH, 2010, 119 (1-3) :101-109
[5]   Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation [J].
De Hert, M. ;
Vancampfort, D. ;
Correll, C. U. ;
Mercken, V. ;
Peuskens, J. ;
Sweers, K. ;
van Winkel, R. ;
Mitchell, A. J. .
BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (02) :99-105
[6]   Validation study of PECC (Psychosis Evaluation tool for Common use by Caregivers):: Interscale validity and inter-rater reliability [J].
De Hert, M ;
Wampers, M ;
Thys, E ;
Wieselgren, IM ;
Lindström, E ;
Peuskens, J .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 (03) :135-140
[7]   Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) [J].
De Hert, M. ;
Dekker, J. M. ;
Wood, D. ;
Kahl, K. G. ;
Holt, R. I. G. ;
Moeller, H. -J. .
EUROPEAN PSYCHIATRY, 2009, 24 (06) :412-424
[8]   Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review [J].
De Hert, Marc ;
Schreurs, Vincent ;
Sweers, Kim ;
Van Eyck, Dominique ;
Hanssens, Linda ;
Sinko, Sebastjan ;
Wampers, Martien ;
Scheen, Andre ;
Peuskens, Joseph ;
van Winkel, Ruud .
SCHIZOPHRENIA RESEARCH, 2008, 101 (1-3) :295-303
[9]  
De Hert M, 2011, WORLD PSYCHIATRY, V10, P138
[10]   Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care [J].
De Hert, Marc ;
Correll, Christoph U. ;
Bobes, Julio ;
Cetkovich-Bakmas, Marcelo ;
Cohen, Dan ;
Asai, Itsuo ;
Detraux, Johan ;
Gautam, Shiv ;
Moeller, Hans-Jurgen ;
Ndetei, David M. ;
Newcomer, John W. ;
Uwakwe, Richard ;
Leucht, Stefan .
WORLD PSYCHIATRY, 2011, 10 (01) :52-77